Net loss of Mangalam Drugs and Organics reported to Rs 7.35 crore in the quarter ended September 2025 as against net profit of Rs 2.69 crore during the previous quarter ended September 2024. Sales declined 38.23% to Rs 49.26 crore in the quarter ended September 2025 as against Rs 79.75 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended | ||
| Sep. 2025 | Sep. 2024 | % Var. | |
| Sales | 49.26 | 79.75 | -38 |
| OPM % | -5.77 | 10.91 | - |
| PBDT | -7.84 | 5.17 | PL |
| PBT | -12.47 | 1.20 | PL |
| NP | -7.35 | 2.69 | PL |
Powered by Capital Market - Live News